- Subbiah, V., Kreitman, R. J., Wainberg, Z. A., Gazzah, A., Lassen, U., Stein, A., Elez Fernandez, E., . . . Bang, Y. -. (2023). Dabrafenib plus trametinib in BRAFV600E-mutated rare cancers: The phase 2 ROAR trial. Nature Medicine. https://doi.org/10.1038/s41591-023-02321-8 (En premsa)
Dabrafenib plus trametinib in BRAFV600E-mutated rare cancers: The phase 2 ROAR trial
on 22 de maig de 2023
with No hi ha comentaris
Deixa un comentari